Thymosin Alpha 1 Had Opposite Immune Effects in Different Mouse Strains
Thymosin alpha 1 worsened autoimmune thyroiditis in resistant mice but reduced it in susceptible mice — showing its effects depend on the host genetic background.
Quick Facts
What This Study Found
Thymosin alpha 1 (Ta-1) had strikingly different effects depending on the mouse strain. In B10.D2 mice (resistant to autoimmune thyroiditis), Ta-1 treatment between the two antigen injections actually increased thyroid inflammation. In B10.Br mice (naturally susceptible), Ta-1 suppressed the disease.
Timing mattered. Early treatment (first 2 weeks) suppressed disease in the susceptible strain but worsened it in the resistant strain. Later treatment (weeks 3-4) had similar patterns.
Different doses affected different T-cell subsets. The 0.01 microgram dose lowered Lyt-2+3+ cells (a type of immune cell) in resistant mice. The 0.001 microgram dose raised Lyt-1+ cells in the same strain. Each dose shifted the immune balance differently, which explains the opposing disease outcomes.
Key Numbers
How They Did This
Two congenic mouse strains (B10.Br and B10.D2) were given experimental autoimmune thyroiditis via thyroglobulin injection. Thymosin alpha 1 was given as 5 or 10 daily subcutaneous injections at doses from 0.0001 to 0.1 microgram. Disease was measured by thyroid lymphocyte infiltration and anti-thyroglobulin antibody levels. T-cell subsets were measured in spleens at 2 weeks.
Why This Research Matters
This study revealed that thymosin alpha 1 is not simply an immune booster. It is an immune modulator that can push the system in either direction depending on the genetic background and disease state. This has important implications for anyone considering thymic peptides for autoimmune conditions.
The Bigger Picture
This study is a critical reminder that immune-modulating peptides are not one-size-fits-all. Genetic background and existing immune state determine whether thymosin alpha 1 helps or hurts, which is essential for clinical application.
What This Study Doesn't Tell Us
This was a mouse study using two specific inbred strains. The complex dose-timing-strain interactions make it hard to predict what would happen in humans. The autoimmune thyroiditis was artificially induced, not spontaneous. Small group sizes are likely given the many experimental conditions.
Questions This Raises
- ?Which human immune profiles respond best to thymosin alpha 1?
- ?Could thymosin alpha 1 worsen certain autoimmune conditions in humans?
- ?What determines whether thymosin alpha 1 suppresses or activates immunity?
Trust & Context
- Key Stat:
- Opposite effects by strain Worsened disease in resistant mice, reduced it in susceptible mice
- Evidence Grade:
- Preliminary animal study using two congenic strains — well-designed for the era but limited to one autoimmune model.
- Study Age:
- Published in 1985 — important early warning about context-dependent effects of immune peptides.
- Original Title:
- Thymosin alpha 1-induced modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.
- Published In:
- Cellular immunology, 93(2), 340-9 (1985)
- Authors:
- Tomazic, V J, Novotny, E A, Ordonez, J V
- Database ID:
- RPEP-00033
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Is thymosin alpha 1 safe for people with autoimmune disease?
This mouse study suggests caution. Thymosin alpha 1 modulates immunity bidirectionally — it could help or worsen autoimmune conditions depending on the individual immune profile. Consult a physician.
What does immune modulator mean?
Unlike a simple immune booster, a modulator can increase or decrease immune activity depending on context. Thymosin alpha 1 adjusts the immune response rather than just amplifying it.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00033APA
Tomazic, V J; Novotny, E A; Ordonez, J V. (1985). Thymosin alpha 1-induced modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.. Cellular immunology, 93(2), 340-9.
MLA
Tomazic, V J, et al. "Thymosin alpha 1-induced modulation of cellular responses and functional T-cell subsets in mice with experimental autoimmune thyroiditis.." Cellular immunology, 1985.
RethinkPeptides
RethinkPeptides Research Database. "Thymosin alpha 1-induced modulation of cellular responses an..." RPEP-00033. Retrieved from https://rethinkpeptides.com/research/tomazic-1985-thymosin-alpha-1induced-modulation
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.